Molecular Medicine

Molecular Medicine S.p.A. is a biotechnology company dedicated to the research, development, production, and clinical validation of gene and cell therapies for cancer and rare diseases. With over 20 years of experience and expertise accumulated through its activities, Molecular Medicine S.p.A. is a reference company in the field of cell and gene therapy, capable of managing all stages of research up to the commercialization of advanced gene and cell therapies. By owning its authorized facilities, Molecular Medicine S.p.A. provides GMP development and manufacturing services for gene and cell therapies by offering resources and experience for research ranging from preclinical stages to commercialization. In the clinical stage, Molecular Medicine S.p.A. conducts R&D activities through its proprietary CAR-T therapy pipeline to treat hematological cancers.